Skip to content
Disclosery

Ikarian Capital, LLC

Follow

13F filer, CIK 1778253, DALLAS, TX

Ikarian Capital, LLC reported $928,174,362 across 156 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 39.52% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-26-001820

Period
2026-06-30
Reported value
$928M
Holdings
156
Top 10 weight
39.52%
New
41
Sold out
46

Part of the filer group Ikarian Capital, LLC

  • Neil Shahrestani
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ABVXadded+271,000$35.7M
RCUSnew+504,559$15.6M
COGTnew+370,084$14.3M
CCCCnew+2,433,000$11.4M
ANIPadded+125,000$10.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TERNexited-1,456,378-$76.8M
CYTKexited-283,572-$18.7M
HROWreduced-407,272-$17.3M
RVMDexited-163,142-$15.9M
ORKAexited-242,021-$11.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001420506-26-001820, largest first. % of portfolio is the value over $610,874,335, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 396,098 shares; 2025Q4: 205,985 shares; 2026Q1: 57,635 shares; 2026Q2: 328,635 shares 328,635$43.4M7.1%+271,000Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 476,586 shares; 2024Q4: 576,166 shares; 2025Q1: 649,534 shares; 2025Q2: 599,534 shares; 2025Q3: 413,841 shares; 2025Q4: 719,787 shares; 2026Q1: 1,265,795 shares; 2026Q2: 1,059,730 shares 1,059,730$41.3M6.76%-206,065Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,213,548 shares; 2026Q2: 870,548 shares 870,548$24.5M4.01%-343,000Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 145,502 shares; 2025Q2: 276,950 shares; 2025Q3: 28,571 shares; 2025Q4: 86,581 shares; 2026Q1: 71,581 shares; 2026Q2: 72,842 shares 72,842$24.4M3.99%+1,261Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 200,000 shares; 2025Q2: 305,000 shares; 2025Q3: 311,682 shares; 2025Q4: 378,682 shares; 2026Q1: 428,682 shares; 2026Q2: 388,682 shares 388,682$22.6M3.7%-40,000Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 147,085 shares; 2026Q2: 272,085 shares 272,085$22.5M3.69%+125,000Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 461,247 shares; 2026Q2: 478,500 shares 478,500$17.8M2.91%+17,253Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 744,000 shares; 2024Q4: 378,363 shares; 2025Q1: 163,363 shares; 2025Q2: 163,363 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 504,559 shares 504,559$15.6M2.55%newTimeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 40,369 shares; 2024Q4: 40,270 shares; 2025Q1: 40,270 shares; 2025Q2: 40,270 shares; 2025Q3: 1,843,060 shares; 2025Q4: 3,068,359 shares; 2026Q1: 2,688,359 shares; 2026Q2: 2,148,359 shares 2,148,359$14.9M2.43%-540,000Timeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 300,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 264,642 shares; 2025Q4: 578,015 shares; 2026Q1: 528,015 shares; 2026Q2: 604,215 shares 604,215$14.5M2.38%+76,200Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,035,528 shares; 2025Q3: 11,280 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 370,084 shares 370,084$14.3M2.34%newTimeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 14,096 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares; 2026Q2: 310,000 shares 310,000$13.3M2.18%+110,000Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 282,874 shares; 2026Q1: 807,874 shares; 2026Q2: 807,874 shares 807,874$13.2M2.17%0Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 967,600 shares; 2025Q4: 967,600 shares; 2026Q1: 1,017,600 shares; 2026Q2: 787,600 shares 787,600$11.5M1.88%-230,000Timeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,433,000 shares 2,433,000$11.4M1.86%newTimeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 322,740 shares; 2025Q2: 262,740 shares; 2025Q3: 740,825 shares; 2025Q4: 644,680 shares; 2026Q1: 378,999 shares; 2026Q2: 378,999 shares 378,999$11.3M1.85%0Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 212,481 shares; 2026Q1: 412,481 shares; 2026Q2: 748,181 shares 748,181$11.1M1.82%+335,700Timeline
CNTBCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,788,486 shares; 2026Q1: 5,388,486 shares; 2026Q2: 4,538,534 shares 4,538,534$10.8M1.77%-849,952Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 350,000 shares; 2025Q1: 175,000 shares; 2025Q2: 110,000 shares; 2025Q3: 110,000 shares; 2025Q4: 515,000 shares; 2026Q1: 515,000 shares; 2026Q2: 407,338 shares 407,338$10.7M1.76%-107,662Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 210,165 shares; 2025Q4: 486,856 shares; 2026Q1: 486,856 shares; 2026Q2: 308,856 shares 308,856$10.7M1.75%-178,000Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 300,000 shares; 2026Q1: 512,349 shares; 2026Q2: 427,349 shares 427,349$9.5M1.55%-85,000Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 285,710 shares; 2026Q1: 335,710 shares; 2026Q2: 335,710 shares 335,710$8.73M1.43%0Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 499,977 shares; 2024Q4: 469,949 shares; 2025Q1: 494,949 shares; 2025Q2: 469,949 shares; 2025Q3: 245,518 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 425,000 shares 425,000$7.81M1.28%newTimeline
PTHSPELTHOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 62,451 shares; 2025Q4: 255,758 shares; 2026Q1: 256,598 shares; 2026Q2: 256,598 shares 256,598$7.25M1.19%0Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,132,322 shares; 2025Q4: 802,322 shares; 2026Q1: 1,193,492 shares; 2026Q2: 1,218,492 shares 1,218,492$7.19M1.18%+25,000Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 267,145 shares; 2024Q4: 142,328 shares; 2025Q1: 269,090 shares; 2025Q2: 163,696 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 157,537 shares; 2026Q2: 205,837 shares 205,837$7.08M1.16%+48,300Timeline
SPRBSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 13,332 shares; 2025Q4: 121,356 shares; 2026Q1: 121,356 shares; 2026Q2: 121,356 shares 121,356$6.55M1.07%0Timeline
HIMSHIMS & HERS HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 188,381 shares 188,381$6.53M1.07%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 499,566 shares; 2024Q4: 394,538 shares; 2025Q1: 289,538 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 126,541 shares 126,541$6.42M1.05%newTimeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 483,583 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 868,069 shares; 2025Q3: 892,229 shares; 2025Q4: 1,492,229 shares; 2026Q1: 1,492,229 shares; 2026Q2: 3,425,930 shares 3,425,930$6.37M1.04%+1,933,701Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 152,211 shares; 2025Q1: 65,431 shares; 2025Q2: 65,431 shares; 2025Q3: 15,431 shares; 2025Q4: 159,421 shares; 2026Q1: 166,647 shares; 2026Q2: 88,951 shares 88,951$6.24M1.02%-77,696Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,095,574 shares; 2025Q4: 247,558 shares; 2026Q1: 2,894,704 shares; 2026Q2: 2,269,704 shares 2,269,704$6.11M1%-625,000Timeline
OCGNOCUGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,962,972 shares; 2026Q2: 3,962,972 shares 3,962,972$6.06M0.99%0Timeline
ACOGALPHA COGNITION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 755,867 shares; 2025Q1: 967,867 shares; 2025Q2: 917,867 shares; 2025Q3: 946,259 shares; 2025Q4: 1,056,259 shares; 2026Q1: 1,056,259 shares; 2026Q2: 836,259 shares 836,259$6.04M0.99%-220,000Timeline
HROWHARROW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 183,347 shares; 2026Q1: 543,047 shares; 2026Q2: 135,775 shares 135,775$5.77M0.94%-407,272Timeline
KZIAKAZIA THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 396,201 shares 396,201$5.58M0.91%newTimeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 179,000 shares; 2024Q4: 178,989 shares; 2025Q1: 216,989 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 12,671 shares; 2026Q1: 482,571 shares; 2026Q2: 165,617 shares 165,617$5.53M0.91%-316,954Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 430,000 shares 430,000$5.48M0.9%newTimeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 610,000 shares; 2026Q1: 1,214,741 shares; 2026Q2: 809,741 shares 809,741$5.35M0.88%-405,000Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares 200,000$4.9M0.8%newTimeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 887,230 shares; 2024Q4: 857,230 shares; 2025Q1: 50,058 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 16,479 shares; 2026Q1: 16,479 shares; 2026Q2: 935,012 shares 935,012$4.86M0.8%+918,533Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 92,000 shares; 2024Q4: 91,994 shares; 2025Q1: 191,994 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 758,654 shares; 2026Q1: 598,281 shares; 2026Q2: 383,281 shares 383,281$4.79M0.78%-215,000Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 5,908 shares; 2025Q1: 5,908 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 47,861 shares 47,861$4.43M0.73%newTimeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 285,613 shares; 2024Q4: 215,713 shares; 2025Q1: 90,837 shares; 2025Q2: not reported; 2025Q3: 51,967 shares; 2025Q4: not reported; 2026Q1: 160,120 shares; 2026Q2: 57,417 shares 57,417$4.28M0.7%-102,703Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 502,601 shares; 2026Q1: 1,429,101 shares; 2026Q2: 1,129,101 shares 1,129,101$4.15M0.68%-300,000Timeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 353,772 shares 353,772$4.1M0.67%newTimeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 950,000 shares; 2025Q1: 950,000 shares; 2025Q2: 900,000 shares; 2025Q3: 760,000 shares; 2025Q4: 2,082,606 shares; 2026Q1: 2,082,606 shares; 2026Q2: 1,982,606 shares 1,982,606$3.99M0.65%-100,000Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 175,100 shares; 2024Q4: 175,088 shares; 2025Q1: 175,088 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 300,000 shares 300,000$3.91M0.64%newTimeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 75,000 shares; 2024Q4: 200,096 shares; 2025Q1: 200,096 shares; 2025Q2: 428,521 shares; 2025Q3: 1,289,225 shares; 2025Q4: 1,375,472 shares; 2026Q1: 1,049,161 shares; 2026Q2: 1,049,161 shares 1,049,161$3.84M0.63%0Timeline
CRDLCARDIOL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,725,000 shares; 2026Q2: 3,325,000 shares 3,325,000$3.52M0.58%+600,000Timeline
CUECUE BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 104,364 shares 104,364$3.29M0.54%newTimeline
CPIXCUMBERLAND PHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 740,000 shares; 2025Q2: 595,932 shares; 2025Q3: 555,932 shares; 2025Q4: 555,932 shares; 2026Q1: 553,153 shares; 2026Q2: 503,153 shares 503,153$3.26M0.53%-50,000Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 38,278 shares 38,278$3.12M0.51%newTimeline
RNTXREIN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,950,000 shares 2,950,000$3.07M0.5%newTimeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 229,900 shares; 2025Q2: 850,000 shares; 2025Q3: 226,257 shares; 2025Q4: 358,257 shares; 2026Q1: 358,257 shares; 2026Q2: 358,257 shares 358,257$2.98M0.49%0Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 266,435 shares; 2024Q4: 265,769 shares; 2025Q1: 265,769 shares; 2025Q2: 265,769 shares; 2025Q3: 265,769 shares; 2025Q4: 254,312 shares; 2026Q1: 1,053,797 shares; 2026Q2: 1,053,797 shares 1,053,797$2.81M0.46%0Timeline
PMNPROMIS NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 55,000 shares; 2026Q2: 205,000 shares 205,000$2.7M0.44%+150,000Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 230,244 shares; 2026Q1: 580,244 shares; 2026Q2: 430,244 shares 430,244$2.46M0.4%-150,000Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 257,216 shares; 2024Q4: 499,301 shares; 2025Q1: 550,029 shares; 2025Q2: 550,029 shares; 2025Q3: 567,601 shares; 2025Q4: 513,011 shares; 2026Q1: 513,011 shares; 2026Q2: 513,011 shares 513,011$2.39M0.39%0Timeline
DCTHDELCATH SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 100,370 shares; 2024Q4: 100,365 shares; 2025Q1: 100,365 shares; 2025Q2: 322,390 shares; 2025Q3: 431,251 shares; 2025Q4: 431,251 shares; 2026Q1: 431,251 shares; 2026Q2: 185,667 shares 185,667$2.34M0.38%-245,584Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,078,706 shares; 2025Q4: 2,656,570 shares; 2026Q1: 2,656,570 shares; 2026Q2: 2,656,570 shares 2,656,570$2.32M0.38%0Timeline
CABACABALETTA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 900,000 shares; 2026Q1: 900,000 shares; 2026Q2: 700,000 shares 700,000$2.18M0.36%-200,000Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 15,457 shares; 2025Q2: 12,498 shares; 2025Q3: 12,498 shares; 2025Q4: 1,278,408 shares; 2026Q1: 1,278,408 shares; 2026Q2: 1,278,408 shares 1,278,408$2.17M0.36%0Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 274,551 shares; 2024Q4: 201,187 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 117,500 shares 117,500$2.11M0.35%newTimeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,030,277 shares; 2024Q4: 607,689 shares; 2025Q1: 485,021 shares; 2025Q2: 196,536 shares; 2025Q3: 73,619 shares; 2025Q4: 31,166 shares; 2026Q1: 31,166 shares; 2026Q2: 31,166 shares 31,166$1.96M0.32%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 587,343 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 873,568 shares; 2025Q3: 900,784 shares; 2025Q4: 865,784 shares; 2026Q1: 865,784 shares; 2026Q2: 830,784 shares 830,784$1.83M0.3%-35,000Timeline
DERMJOURNEY MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 251,436 shares; 2026Q1: 251,436 shares; 2026Q2: 251,436 shares 251,436$1.78M0.29%0Timeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 525,000 shares; 2026Q1: 525,000 shares; 2026Q2: 525,000 shares 525,000$1.69M0.28%0Timeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 600,000 shares; 2024Q4: 599,913 shares; 2025Q1: 599,913 shares; 2025Q2: 599,913 shares; 2025Q3: 617,327 shares; 2025Q4: 957,062 shares; 2026Q1: 957,062 shares; 2026Q2: 957,062 shares 957,062$1.67M0.27%0Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 970,359 shares; 2024Q4: 970,259 shares; 2025Q1: 200,000 shares; 2025Q2: 35,300 shares; 2025Q3: 159,777 shares; 2025Q4: 31,106 shares; 2026Q1: not reported; 2026Q2: 90,183 shares 90,183$1.67M0.27%newTimeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 366,571 shares; 2026Q2: 166,571 shares 166,571$1.64M0.27%-200,000Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 274,978 shares; 2026Q1: 274,978 shares; 2026Q2: 750,000 shares 750,000$1.57M0.26%+475,022Timeline
AMANAMANAT ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,000 shares 150,000$1.52M0.25%newTimeline
KLRSKALARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 360,000 shares; 2026Q1: 360,000 shares; 2026Q2: 360,000 shares 360,000$1.47M0.24%0Timeline
QNCXQUINCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 72,251 shares 72,251$1.31M0.22%newTimeline
LPCNLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 199,542 shares; 2026Q1: 508,556 shares; 2026Q2: 508,556 shares 508,556$1.3M0.21%0Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 60,000 shares 60,000$1.27M0.21%newTimeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,000,000 shares 1,000,000$1.14M0.19%newTimeline
IMUXIMMUNIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 67,464 shares 67,464$1.04M0.17%newTimeline
QNRXQUOIN PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 211,538 shares; 2026Q1: 211,538 shares; 2026Q2: 211,538 shares 211,538$1.02M0.17%02026-09-30, 13G/A: 211,538 shares, 4.4% of the class, 13G/A filed 2026-10-07 Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 332,297 shares; 2025Q4: 303,555 shares; 2026Q1: 303,555 shares; 2026Q2: 303,555 shares 303,555$971K0.16%0Timeline
STIMNEURONETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,100,000 shares; 2025Q2: 1,099,700 shares; 2025Q3: 905,716 shares; 2025Q4: 701,182 shares; 2026Q1: 701,182 shares; 2026Q2: 701,182 shares 701,182$912K0.15%0Timeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,497 shares; 2025Q3: 22,497 shares; 2025Q4: 21,351 shares; 2026Q1: 6,351 shares; 2026Q2: 35,386 shares 35,386$885K0.14%+29,035Timeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,800,000 shares; 2025Q4: 1,100,000 shares; 2026Q1: 1,100,000 shares; 2026Q2: 1,100,000 shares 1,100,000$874K0.14%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 367,195 shares; 2024Q4: 397,175 shares; 2025Q1: 397,175 shares; 2025Q2: 140,475 shares; 2025Q3: 140,475 shares; 2025Q4: 132,153 shares; 2026Q1: 132,153 shares; 2026Q2: 132,153 shares 132,153$874K0.14%0Timeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 42,775 shares 42,775$861K0.14%newTimeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 213,865 shares; 2026Q1: 213,865 shares; 2026Q2: 213,865 shares 213,865$817K0.13%0Timeline
LABDDIREXION SHARES ETF TRUSTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 91,959 shares; 2025Q4: 40,822 shares; 2026Q1: 105,822 shares; 2026Q2: 105,822 shares 105,822$816K0.13%0Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 150,000 shares; 2025Q2: 150,000 shares; 2025Q3: 535,967 shares; 2025Q4: 447,165 shares; 2026Q1: 447,165 shares; 2026Q2: 447,165 shares 447,165$805K0.13%0Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 28,099 shares; 2026Q2: 28,099 shares 28,099$711K0.12%0Timeline
CNSPCNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,830 shares; 2026Q1: 45,830 shares; 2026Q2: 135,830 shares 135,830$649K0.11%+90,000Timeline
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 43,799 shares; 2025Q3: 43,799 shares; 2025Q4: 41,081 shares; 2026Q1: 41,081 shares; 2026Q2: 41,081 shares 41,081$577K0.09%0Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 544,265 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 161,137 shares; 2025Q3: 95,955 shares; 2025Q4: 85,285 shares; 2026Q1: 85,285 shares; 2026Q2: 85,285 shares 85,285$496K0.08%0Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 49,415 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 49,396 shares; 2025Q3: 49,396 shares; 2025Q4: 48,569 shares; 2026Q1: 48,569 shares; 2026Q2: 48,569 shares 48,569$492K0.08%0Timeline
PASGPASSAGE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 68,124 shares; 2026Q2: 99,517 shares 99,517$486K0.08%+31,393Timeline
NXTCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 238,303 shares; 2026Q1: 238,303 shares; 2026Q2: 288,303 shares 288,303$461K0.08%+50,000Timeline
FBRXFORTE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 609,225 shares; 2025Q1: 609,225 shares; 2025Q2: 476,443 shares; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 118,972 shares; 2026Q2: 20,972 shares 20,972$446K0.07%-98,000Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 230,000 shares; 2025Q2: not reported; 2025Q3: 176,690 shares; 2025Q4: 160,409 shares; 2026Q1: 264,409 shares; 2026Q2: 42,956 shares 42,956$429K0.07%-221,453Timeline
TRAWTRAWS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 98,493 shares; 2025Q1: 28,493 shares; 2025Q2: 28,493 shares; 2025Q3: 28,493 shares; 2025Q4: 678,142 shares; 2026Q1: 678,142 shares; 2026Q2: 478,142 shares 478,142$403K0.07%-200,000Timeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 1,550,000 shares; 2025Q1: 1,417,952 shares; 2025Q2: 176,479 shares; 2025Q3: 176,479 shares; 2025Q4: 164,674 shares; 2026Q1: 164,674 shares; 2026Q2: 164,674 shares 164,674$395K0.06%0Timeline
ELTXELICIO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,000 shares 100,000$391K0.06%newTimeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 33,899 shares; 2026Q2: 33,899 shares 33,899$390K0.06%0Timeline
INMINMED PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 245,025 shares 245,025$380K0.06%newTimeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 50,000 shares; 2025Q2: 100,000 shares; 2025Q3: 10,000 shares; 2025Q4: 9,717 shares; 2026Q1: 9,717 shares; 2026Q2: 9,717 shares 9,717$379K0.06%0Timeline
MGNXMACROGENICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 80,079 shares; 2024Q4: 80,071 shares; 2025Q1: 80,071 shares; 2025Q2: 80,071 shares; 2025Q3: 80,071 shares; 2025Q4: 74,893 shares; 2026Q1: 74,893 shares; 2026Q2: 74,893 shares 74,893$346K0.06%0Timeline
PURRHYPERLIQUID STRATEGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,001 shares; 2026Q1: 30,001 shares; 2026Q2: 30,001 shares 30,001$236K0.04%0Timeline
EVAXEVAXION ASQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 80,000 shares; 2025Q2: 80,000 shares; 2025Q3: 80,000 shares; 2025Q4: 74,698 shares; 2026Q1: 74,698 shares; 2026Q2: 74,698 shares 74,698$232K0.04%0Timeline
RNACCARTESIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 52,193 shares; 2024Q4: 52,166 shares; 2025Q1: 22,166 shares; 2025Q2: 22,166 shares; 2025Q3: 22,166 shares; 2025Q4: 20,807 shares; 2026Q1: 20,807 shares; 2026Q2: 20,807 shares 20,807$217K0.04%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 202,908 shares; 2024Q4: 202,894 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 400,000 shares; 2026Q1: 675,000 shares; 2026Q2: 15,000 shares 15,000$212K0.03%-660,000Timeline
NEUPNEUPHORIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 47,443 shares; 2026Q1: 47,443 shares; 2026Q2: 47,443 shares 47,443$207K0.03%0Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 55,857 shares; 2024Q4: 55,766 shares; 2025Q1: 55,766 shares; 2025Q2: 55,766 shares; 2025Q3: 55,766 shares; 2025Q4: 53,063 shares; 2026Q1: 53,063 shares; 2026Q2: 53,063 shares 53,063$186K0.03%0Timeline
VYNEVYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 290,000 shares; 2025Q3: 290,000 shares; 2025Q4: 264,912 shares; 2026Q1: 264,912 shares; 2026Q2: 264,912 shares 264,912$172K0.03%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 16,756 shares 16,756$168K0.03%newTimeline
ENVBENVERIC BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,002 shares 100,002$138K0.02%newTimeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 97,500 shares; 2025Q4: 89,136 shares; 2026Q1: 89,136 shares; 2026Q2: 89,136 shares 89,136$119K0.02%0Timeline
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 77,616 shares; 2025Q1: 601,703 shares; 2025Q2: 601,703 shares; 2025Q3: 620,869 shares; 2025Q4: 519,077 shares; 2026Q1: 519,077 shares; 2026Q2: 519,077 shares 519,077$117K0.02%0Timeline
CMMBCHEMOMAB THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 53,262 shares; 2025Q4: 51,793 shares; 2026Q1: 51,793 shares; 2026Q2: 51,793 shares 51,793$83.9K0.01%0Timeline
NYXHNYXOAH S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 50,699 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,627 shares; 2025Q3: 50,627 shares; 2025Q4: 47,358 shares; 2026Q1: 47,358 shares; 2026Q2: 47,358 shares 47,358$80K0.01%0Timeline
AIRSAIRSCULPT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 17,951 shares; 2025Q3: 17,951 shares; 2025Q4: 16,398 shares; 2026Q1: 16,398 shares; 2026Q2: 16,398 shares 16,398$73.8K0.01%0Timeline
MGRXMANGOCEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 138,146 shares; 2026Q1: 138,146 shares; 2026Q2: 138,146 shares 138,146$52.5K0.01%0Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 800,000 shares; 2026Q1: 18,000 shares; 2026Q2: 18,000 shares 18,000$39.4K0.01%0Timeline
TOVXTHERIVA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 120,031 shares; 2025Q2: 120,031 shares; 2025Q3: 120,031 shares; 2025Q4: 112,076 shares; 2026Q1: 112,076 shares; 2026Q2: 112,076 shares 112,076$28K<0.01%0Timeline
GCTKGLUCOTRACK INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,830 shares; 2026Q1: 45,830 shares; 2026Q2: 45,830 shares 45,830$14.6K<0.01%0Timeline
AEMDAETHLON MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 14,364 shares; 2026Q1: 14,364 shares; 2026Q2: 14,364 shares 14,364$11.8K<0.01%0Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 55,175 shares; 2024Q4: 55,107 shares; 2025Q1: 25,107 shares; 2025Q2: 25,107 shares; 2025Q3: 25,107 shares; 2025Q4: 24,093 shares; 2026Q1: 24,093 shares; 2026Q2: 24,093 shares 24,093$10.1K<0.01%0Timeline
PHGEBIOMX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 19,473 shares; 2026Q1: 19,473 shares; 2026Q2: 19,473 shares 19,473$6.77K<0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
XBISPDR SERIES TRUST S&P BIOTECHput300,000$47.5M-500,000
ABVXABIVAX SA SPONSORED ADScall341,100$45.5M+47,800
ABVXABIVAX SA SPONSORED ADSput250,000$33.3Mnew
IONSIONIS PHARMACEUTICALS INC Stockcall400,000$31.7M+287,900
MRNAMODERNA INC COMput400,000$28Mnew
IONSIONIS PHARMACEUTICALS INC Stockput300,000$23.8Mnew
NEWAMSTERDAM PHARMA COMPANYNEWAMSTERDAM PHARMA COMPANY PUTput400,000$13.6Mnew
ALMSALUMIS INC COMcall356,300$10M+91,700
KODKODIAK SCIENCES INC COMcall217,700$8.48M+117,700
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKcall350,000$8.43M0
ARWRARROWHEAD PHARMACEUTICALS IN COMput100,000$8.15M+42,500
PRAXPRAXIS PRECISION MEDICINES I COM NEWcall20,000$6.7Mnew
KYMRKYMERA THERAPEUTICS INC COMput50,400$5.78M0
TENXTENAX THERAPEUTICS INC COM NEWcall373,100$5.43M+258,800
EYPTEYEPOINT INC Stockput370,400$5.3M0
EYPTEYEPOINT INC Stockcall370,400$5.3M0
SLSSELLAS LIFE SCIENCES GROUP I COM NEWput354,700$5.24Mnew
SIONSIONNA THERAPEUTICS INC COMMON STOCKput107,500$4.73Mnew
CLDXCELLDEX THERAPEUTICS INC NEW COM NEWput114,000$4.24M0
VERAVERA THERAPEUTICS INC COMMON STOCKcall71,700$3.08M0
QTTBQ32 BIO INC Common Stockput200,000$2.55Mnew
OLMAOLEMA PHARMACEUTICALS INC COMcall200,000$2.5M-349,800
BMYBRISTOL-MYERS SQUIBB CO COMput42,500$2.45M-457,500
UNIQURE NVUNIQURE NV CALLcall49,800$2.29M-305,200
IRONDISC MEDICINE INC Stockput13,300$973Knew
IRONDISC MEDICINE INC Stockcall13,300$973Knew
ELTXELICIO THERAPEUTICS INC LST Equity Optionput107,100$419Knew
ELTXELICIO THERAPEUTICS INC LST Equity Optioncall107,100$419Knew
PRAXPRAXIS PRECISION MEDICINES I COM NEWput900$301Knew
TENXTENAX THERAPEUTICS INC COM NEWput16,500$240Knew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TERNTERNS PHARMACEUTICALS INC1,456,378$76.8Mshares
TERNTERNS PHARMACEUTICALS INC1,200,000$63.3Mput
QQQINVESCO QQQ TR100,000$57.7Mput
IWMISHARES TR200,000$49.6Mput
CYTKCYTOKINETICS INC550,500$36.3Mput
CYTKCYTOKINETICS INC408,400$26.9Mcall
CYTKCYTOKINETICS INC283,572$18.7Mshares
RVMDREVOLUTION MEDICINES INC163,142$15.9Mshares
NVONOVO-NORDISK A S400,000$14.7Mcall
ORKAORUKA THERAPEUTICS INC242,021$11.9Mshares
ANIPANI PHARMACEUTICALS INC150,000$11.5Mcall
SLNOSOLENO THERAPEUTICS INC344,123$11.5Mshares
IONSIONIS PHARMACEUTICALS INC127,038$9.54Mshares
RVMDREVOLUTION MEDICINES INC95,000$9.24Mput
PVLAPALVELLA THERAPEUTICS INC NE64,626$8.06Mshares
LLYELI LILLY & CO6,547$6.02Mshares
AVTXAVALO THERAPEUTICS INC401,500$5.99Mcall
KPTIKARYOPHARM THERAPEUTICS INC920,000$5.12Mput
KPTIKARYOPHARM THERAPEUTICS INC920,000$5.12Mcall
SRZNSURROZEN INC173,107$5.04Mshares
BBIOBRIDGEBIO PHARMA INC58,500$4.34Mcall
LEGNLEGEND BIOTECH CORP226,888$4.1Mshares
KPTIKARYOPHARM THERAPEUTICS INC733,435$4.09Mshares
ELVNENLIVEN THERAPEUTICS INC83,700$3.28Mput
FRNMPERCEPTIVE CAP SOLUTIONS COR240,951$2.64Mshares
VIRVIR BIOTECHNOLOGY INC293,258$2.63Mshares
BBOTBRIDGEBIO ONCOLOGY THERAPEUT270,231$2.42Mshares
NUVLNUVALENT INC23,594$2.42Mshares
AVTXAVALO THERAPEUTICS INC158,500$2.37Mput
JAZZJAZZ PHARMACEUTICALS PLC12,460$2.36Mshares
REPLREPLIMUNE GROUP INC300,000$2.29Mput
QUREUNIQURE NV91,060$1.49Mshares
DFTXDEFINIUM THERAPEUTICS INC58,803$1.11Mshares
KZRKEZAR LIFE SCIENCES INC102,211$758Kshares
IMUXIMMUNIC INC674,662$749Kshares
CNTACENTESSA PHARMACEUTICALS PLC18,113$719Kshares
KALVKALVISTA PHARMACEUTICALS INC35,119$707Kshares
INSMINSMED INC4,214$689Kshares
PEPGPEPGEN INC300,000$531Kcall
MAZEMAZE THERAPEUTICS INC14,400$430Kput
CNTBCONNECT BIOPHARMA HLDGS LTD144,600$379Kcall
SGMOSANGAMO THERAPEUTICS INC1,218,671$301Kshares
VERUVERU INC133,517$295Kshares
IOBTQIO BIOTECH INC1,386,565$81.4Kshares
SHPHSHUTTLE PHARMACTCLS HLDGS IN68,993$46.8Kshares
AMIXAUTONOMIX MED INC18,688$7.29Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-001820 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13G/A 0001778253-26-000004 QNRX2026-10-07
13F-HR 0001420506-26-001820 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001420506-26-001165 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001420506-26-000592 Quarter ended 2025-12-312026-02-18acceptance time not in the bulk data set
13F-HR 0001420506-25-003413 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001420506-25-002181 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001420506-25-001276 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001420506-25-000610 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001420506-24-002562 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001420506-24-001556 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR/A 0001420506-24-001013 Quarter ended 2024-03-312024-05-17acceptance time not in the bulk data set
13F-HR 0001420506-24-001000 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001420506-24-000473 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001420506-23-002207 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001420506-23-001546 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001420506-23-001082 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001420506-23-000695 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001420506-22-002295 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001420506-22-001577 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0001420506-22-000935 Quarter ended 2022-03-312022-05-13acceptance time not in the bulk data set
13F-HR 0001420506-22-000377 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001420506-21-001587 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR/A 0001420506-21-001327 Quarter ended 2021-06-302021-08-18acceptance time not in the bulk data set
13F-HR/A 0001420506-21-001325 Quarter ended 2021-03-312021-08-18acceptance time not in the bulk data set
13F-HR 0001420506-21-001161 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001420506-21-000702 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001420506-21-000255 Quarter ended 2020-12-312021-02-12acceptance time not in the bulk data set
13F-HR 0001420506-20-001296 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001420506-20-000923 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001420506-20-000607 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001420506-20-000073 Quarter ended 2019-12-312020-01-31acceptance time not in the bulk data set